The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Anticoagulant Reversal Drug Market Research Report 2025
Synopsis
The global Oral Anticoagulant Reversal Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Oral Anticoagulant Reversal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anticoagulant Reversal Drug.
Report Scope
The Oral Anticoagulant Reversal Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Anticoagulant Reversal Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Anticoagulant Reversal Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals
Segment by Type
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Anticoagulant Reversal Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Oral Anticoagulant Reversal Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Oral Anticoagulant Reversal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anticoagulant Reversal Drug.
Report Scope
The Oral Anticoagulant Reversal Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Anticoagulant Reversal Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Anticoagulant Reversal Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals
Segment by Type
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Anticoagulant Reversal Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prothrombin Complex Concentrates
1.2.3 Vitamin K
1.2.4 Protamine
1.2.5 Tranexamic Acid
1.3 Market by Application
1.3.1 Global Oral Anticoagulant Reversal Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Anticoagulant Reversal Drug Market Perspective (2019-2030)
2.2 Oral Anticoagulant Reversal Drug Growth Trends by Region
2.2.1 Global Oral Anticoagulant Reversal Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Anticoagulant Reversal Drug Historic Market Size by Region (2019-2024)
2.2.3 Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2025-2030)
2.3 Oral Anticoagulant Reversal Drug Market Dynamics
2.3.1 Oral Anticoagulant Reversal Drug Industry Trends
2.3.2 Oral Anticoagulant Reversal Drug Market Drivers
2.3.3 Oral Anticoagulant Reversal Drug Market Challenges
2.3.4 Oral Anticoagulant Reversal Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Anticoagulant Reversal Drug Players by Revenue
3.1.1 Global Top Oral Anticoagulant Reversal Drug Players by Revenue (2019-2024)
3.1.2 Global Oral Anticoagulant Reversal Drug Revenue Market Share by Players (2019-2024)
3.2 Global Oral Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Anticoagulant Reversal Drug Revenue
3.4 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio
3.4.1 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Anticoagulant Reversal Drug Revenue in 2023
3.5 Oral Anticoagulant Reversal Drug Key Players Head office and Area Served
3.6 Key Players Oral Anticoagulant Reversal Drug Product Solution and Service
3.7 Date of Enter into Oral Anticoagulant Reversal Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Anticoagulant Reversal Drug Breakdown Data by Type
4.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Type (2019-2024)
4.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2025-2030)
5 Oral Anticoagulant Reversal Drug Breakdown Data by Application
5.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Application (2019-2024)
5.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Anticoagulant Reversal Drug Market Size (2019-2030)
6.2 North America Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024)
6.4 North America Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Anticoagulant Reversal Drug Market Size (2019-2030)
7.2 Europe Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024)
7.4 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size (2019-2030)
8.2 Asia-Pacific Oral Anticoagulant Reversal Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Anticoagulant Reversal Drug Market Size (2019-2030)
9.2 Latin America Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024)
9.4 Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size (2019-2030)
10.2 Middle East & Africa Oral Anticoagulant Reversal Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Detail
11.1.2 Bausch Health Companies Business Overview
11.1.3 Bausch Health Companies Oral Anticoagulant Reversal Drug Introduction
11.1.4 Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.1.5 Bausch Health Companies Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Anticoagulant Reversal Drug Introduction
11.2.4 Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Oral Anticoagulant Reversal Drug Introduction
11.3.4 Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.3.5 Fresenius Kabi Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Detail
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Oral Anticoagulant Reversal Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 CSL
11.6.1 CSL Company Detail
11.6.2 CSL Business Overview
11.6.3 CSL Oral Anticoagulant Reversal Drug Introduction
11.6.4 CSL Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.6.5 CSL Recent Development
11.7 Octapharma
11.7.1 Octapharma Company Detail
11.7.2 Octapharma Business Overview
11.7.3 Octapharma Oral Anticoagulant Reversal Drug Introduction
11.7.4 Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.7.5 Octapharma Recent Development
11.8 Portola Pharmaceuticals
11.8.1 Portola Pharmaceuticals Company Detail
11.8.2 Portola Pharmaceuticals Business Overview
11.8.3 Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.8.4 Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.8.5 Portola Pharmaceuticals Recent Development
11.9 Perosphere Pharmaceuticals
11.9.1 Perosphere Pharmaceuticals Company Detail
11.9.2 Perosphere Pharmaceuticals Business Overview
11.9.3 Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.9.4 Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024)
11.9.5 Perosphere Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prothrombin Complex Concentrates
Table 3. Key Players of Vitamin K
Table 4. Key Players of Protamine
Table 5. Key Players of Tranexamic Acid
Table 6. Global Oral Anticoagulant Reversal Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Oral Anticoagulant Reversal Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oral Anticoagulant Reversal Drug Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Oral Anticoagulant Reversal Drug Market Share by Region (2019-2024)
Table 10. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Oral Anticoagulant Reversal Drug Market Share by Region (2025-2030)
Table 12. Oral Anticoagulant Reversal Drug Market Trends
Table 13. Oral Anticoagulant Reversal Drug Market Drivers
Table 14. Oral Anticoagulant Reversal Drug Market Challenges
Table 15. Oral Anticoagulant Reversal Drug Market Restraints
Table 16. Global Oral Anticoagulant Reversal Drug Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Oral Anticoagulant Reversal Drug Market Share by Players (2019-2024)
Table 18. Global Top Oral Anticoagulant Reversal Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2023)
Table 19. Ranking of Global Top Oral Anticoagulant Reversal Drug Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Oral Anticoagulant Reversal Drug Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral Anticoagulant Reversal Drug Product Solution and Service
Table 23. Date of Enter into Oral Anticoagulant Reversal Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Anticoagulant Reversal Drug Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2019-2024)
Table 27. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2025-2030)
Table 29. Global Oral Anticoagulant Reversal Drug Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Application (2019-2024)
Table 31. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Application (2025-2030)
Table 33. North America Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bausch Health Companies Company Detail
Table 49. Bausch Health Companies Business Overview
Table 50. Bausch Health Companies Oral Anticoagulant Reversal Drug Product
Table 51. Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 52. Bausch Health Companies Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Oral Anticoagulant Reversal Drug Product
Table 56. Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Fresenius Kabi Company Detail
Table 59. Fresenius Kabi Business Overview
Table 60. Fresenius Kabi Oral Anticoagulant Reversal Drug Product
Table 61. Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 62. Fresenius Kabi Recent Development
Table 63. Amneal Pharmaceuticals Company Detail
Table 64. Amneal Pharmaceuticals Business Overview
Table 65. Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 66. Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 67. Amneal Pharmaceuticals Recent Development
Table 68. Boehringer Ingelheim Company Detail
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Oral Anticoagulant Reversal Drug Product
Table 71. Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. CSL Company Detail
Table 74. CSL Business Overview
Table 75. CSL Oral Anticoagulant Reversal Drug Product
Table 76. CSL Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 77. CSL Recent Development
Table 78. Octapharma Company Detail
Table 79. Octapharma Business Overview
Table 80. Octapharma Oral Anticoagulant Reversal Drug Product
Table 81. Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 82. Octapharma Recent Development
Table 83. Portola Pharmaceuticals Company Detail
Table 84. Portola Pharmaceuticals Business Overview
Table 85. Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 86. Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 87. Portola Pharmaceuticals Recent Development
Table 88. Perosphere Pharmaceuticals Company Detail
Table 89. Perosphere Pharmaceuticals Business Overview
Table 90. Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 91. Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2019-2024) & (US$ Million)
Table 92. Perosphere Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Anticoagulant Reversal Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oral Anticoagulant Reversal Drug Market Share by Type: 2023 VS 2030
Figure 3. Prothrombin Complex Concentrates Features
Figure 4. Vitamin K Features
Figure 5. Protamine Features
Figure 6. Tranexamic Acid Features
Figure 7. Global Oral Anticoagulant Reversal Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oral Anticoagulant Reversal Drug Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Others Case Studies
Figure 12. Oral Anticoagulant Reversal Drug Report Years Considered
Figure 13. Global Oral Anticoagulant Reversal Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Oral Anticoagulant Reversal Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Oral Anticoagulant Reversal Drug Market Share by Region: 2023 VS 2030
Figure 16. Global Oral Anticoagulant Reversal Drug Market Share by Players in 2023
Figure 17. Global Top Oral Anticoagulant Reversal Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Oral Anticoagulant Reversal Drug Revenue in 2023
Figure 19. North America Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Oral Anticoagulant Reversal Drug Market Share by Country (2019-2030)
Figure 21. United States Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Oral Anticoagulant Reversal Drug Market Share by Country (2019-2030)
Figure 25. Germany Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Oral Anticoagulant Reversal Drug Market Share by Region (2019-2030)
Figure 33. China Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Oral Anticoagulant Reversal Drug Market Share by Country (2019-2030)
Figure 41. Mexico Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Oral Anticoagulant Reversal Drug Market Share by Country (2019-2030)
Figure 45. Turkey Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bausch Health Companies Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 49. Fresenius Kabi Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 50. Amneal Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 52. CSL Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 53. Octapharma Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 54. Portola Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 55. Perosphere Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
